OXYCONTIN

KH
Karen Hadley in Legislation
February 6, 2022

A First-Hand Account of The Empire of Pain

For anyone touched by America’s opioid epidemic and anyone who has followed the development of this crisis, as I have, Patrick Radden Keefe’s new book adds to our knowledge of the steps that must be taken to heal from our crisis of drugs abuse and overdoses.

read more...

Ren in Legislation
February 4, 2022

Criminal Acts: How Pharma Companies Pushed Drugs They Knew Were Addictive and Dangerous

The Sackler Family and Purdue Pharmaceuticals deny any responsibility for the role they played in creating the opioid addiction epidemic. And while the most recent litigation against Purdue/the Sackler family ended in immunity for them and an abdication of responsibility, it wasn't too long ago that Purdue was pleading guilty to federal felony charges relating to the opioid crisis.

read more...

Ren in Legislation
December 1, 2021

New Developments in the Sackler Case Suggest More Needs to be Done to Hold Pharma Magnates Accountable

In the late-1990s and early-2000s, pharmaceutical manufacturers like Purdue Pharma aggressively marketed addictive drugs such as OxyContin, pushing doctors to prescribe them. Today, though it’s known that these companies helped create America’s opioid epidemic, the owners of the companies appear poised to escape accountability.

read more...

KH

Deadly Counterfeit Pills Continue to Escalate Deaths

The presence of millions of counterfeit prescription drugs that actually contain fentanyl or other dangerous illicit drugs makes drug abuse more dangerous than ever. Just one pill can kill the unwary. We look at why and where this situation exists.

read more...

Ren in Legislation
September 25, 2021

The Sackler Case Comes to a Close; Final Analysis and the Importance of Holding Pharma Companies Accountable

Consider this: Purdue Pharmaceuticals/the Sacklers versus thousands of plaintiffs nationwide. It was one of the most closely watched pharmaceutical litigations of our time, and it just came to a close. While there were some small victories in the case, many see its outcome as a loss for those who suffered at the hands of Purdue’s addictive opioid painkiller, OxyContin.

read more...

Ren in Opioid Crisis
January 2, 2021

Pharma Giant Hit with Criminal Charges and $8 Billion Lawsuit

It matters how businesses make their money. For Purdue Pharma, this multi-billion dollar corporation is being shut down due to the deaths caused by its frontline product, OxyContin. But is shutting the company down enough?

read more...

Ren in Drug-Related News
December 17, 2020

Maker of OxyContin Loses Criminal Lawsuit—Transform to Non-Profit and Pay $8 Billion

In a breaking news story that spread like wildfire across the U.S., the American people were informed that Purdue Pharmaceuticals, maker of OxyContin, had agreed to plead guilty to federal, criminal charges. Why?

read more...

Ren in Pharmaceutical Companies
November 2, 2020

OxyContin Maker Closed, Fined $8 Billion

The maker of OxyContin, Purdue Pharma, has agreed to plead guilty to three federal criminal charges for its role in creating and advancing the nation's opioid epidemic. Unfortunately, this does not even come close to holding Purdue accountable for the damage it caused.

read more...

Ren in Opioids
June 7, 2019

Treating Pain While Avoiding Addiction—How Can We Help Pain Patients and Also Reduce Opioid Consumption?

An article in the Washington Post from early April 2019 focuses on Kirsten Gillibrand, a Senator from New York and a possible contender for the presidential candidacy in 2020. The article discusses Gillibrand’s efforts to curb the opioid crisis and the criticism she has received in doing so.

read more...

KH
Karen Hadley in Drug-Related News
February 26, 2019

Increase in Pet Painkiller Prescriptions Could Indicate More Owner Misuse

Because of a significant increase in painkiller prescriptions to pet owners, veterinarians are being warned to watch for some owners who might be consuming these drugs instead of giving them to their pets.

read more...